Literature DB >> 12470054

Synthesis, structure, and second-order nonlinear optical properties of copper(II) and palladium(II) acentric complexes with N-salicylidene-N'-aroylhydrazine tridentate ligands.

F Cariati1, U Caruso, R Centore, W Marcolli, A De Maria, B Panunzi, A Roviello, A Tuzi.   

Abstract

Two new N-salicylidene-N'-aroylhydrazines ligands have been prepared: N-4-diethylaminosalicylidene-N'-4-nitrobenzoyl-hydrazine (L(1)) and N-4-diethylaminosalicylidene-N'-4-(4-nitrophenylethylidene)-benzoyl-hydrazine (L(2)). The ligands are properly functionalized with strong electron donor-acceptor groups and are of potential interest in second-order nonlinear optics (NLO). Dimeric copper(II) and palladium(II) complexes with L(1) and L(2) have been prepared, and, starting from these, mononuclear acentric adducts with pyridine as a further ligand have been prepared and characterized. The X-ray structures of three adducts are also reported. The NLO activity of the adducts has been determined by EFISH measurements giving mubeta values up to 1500 x 10(-48) esu for an incident wavelength of 1.907 microm.

Entities:  

Year:  2002        PMID: 12470054     DOI: 10.1021/ic020127k

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  [N'-(4-Meth-oxy-2-oxidobenzyl-idene)4-nitro-benzohydrazidato-κO,N,O'](pyridine-κN)copper(II).

Authors:  Nooraziah Mohd Lair; Hapipah Mohd Ali; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-12-20

2.  (Acetyl-acetonato-κO,O')aqua-[2-(2-nitro-phen-oxy)-N'-(2-oxidobenzyl-idene-κO)acetohydrazidato-κO,N']manganese(III).

Authors:  Zi-Jing Xiao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-25

3.  Chloridobis[N'-(2-meth-oxy-benzyl-idene)-4-nitro-benzohydrazidato-κO,N'](4-methyl-pyridine-κN)cobalt(III).

Authors:  Qiong-Jie Wu; Xiao-Hua Chen; Jiang Jiang; Bi-Qiong Cai; Yong-Ping Xie
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.